Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
4.680
-0.290 (-5.84%)
Aug 5, 2026, 4:00 PM EDT - Market closed
Rezolute Market Cap
Rezolute has a market cap or net worth of $488.9 million as of August 5, 2026. Its market cap has decreased by -3.11% in one year.
Market Cap
488.90M
Enterprise Value
369.75M
1-Year Change
-3.11%
Ranking
Category
Stock Price
$4.68
ChartMarket Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $488.90M, an increase of 192.76%. That is a compound annual growth rate of 20.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 450.60M | 105.94% |
| Dec 31, 2025 | 218.80M | -22.93% |
| Dec 31, 2024 | 283.90M | 622.39% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
| Nov 10, 2020 | 167.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Adlai Nortye | 520.00M |
| Arvinas | 518.11M |
| Zura Bio | 515.84M |
| Verastem | 509.67M |
| ARS Pharmaceuticals | 509.43M |
| Eikon Therapeutics | 498.62M |
| Silence Therapeutics | 495.48M |
| Artiva Biotherapeutics | 490.74M |